[The effects of blood glucose lowering biguanides on liver metabolism].
D000255:Adenosine Triphosphate / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001645:Biguanides; D003921:Diabetes Mellitus, Experimental; D004285:Dogs; D005943:Gluconeogenesis / Q000187:drug effects; D006146:Guanidines / Q000494:pharmacology; D007004:Hypoglycemic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008112:Liver Glycogen / Q000032:analysis; D051379:Mice; D008930:Mitochondria, Liver / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D010710:Phosphates / Q000378:metabolism; D010735:Phosphoglycerate Kinase / Q000037:antagonists & inhibitors; D051381:Rats; D014508:Urea / Q000378:metabolism
D000596:Amino Acids; D001645:Biguanides; D006146:Guanidines; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D010710:Phosphates; D000255:Adenosine Triphosphate; D014508:Urea; D010735:Phosphoglycerate Kinase